Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ex Vivo Lung Perfusion in Bergamo Lung Transplant Program: A Prospective Observational Study

NCT03053349 is registered in ClinicalTrials.gov with Papa Giovanni XXIII Hospital as lead sponsor.

NCT NCT03053349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03053349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ex Vivo Lung Perfusion in Bergamo Lung Transplant Program: A Prospective Observational Study
Lead sponsor
Papa Giovanni XXIII Hospital
Phase
Observational
Overall status
Completed
Start date
April 12, 2017
Completion date
December 6, 2020
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ex vivo lung perfusion, lung transplantation